Diversified Trust Co Cuts Position in Blueprint Medicines Co. (NASDAQ:BPMC)
Diversified Trust Co lowered its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 52.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the ...
Science Daily23m
A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior
A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...
News Medical on MSN21h
Research explores molecular dynamics of CAR T cells in cancer treatment
A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer.